QUEST FOR GROWTH NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.6 EUR | +0.44% |
|
0.00% | -8.00% |
| Jan. 25 | Quest for Growth NV Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Quest for Growth NV Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| Sales 2024 * | - | Sales 2025 * | - | Capitalization | 86.17M 80.75M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 5 |
| Yield 2024 * |
4.35% | Yield 2025 * |
6.52% | Free-Float | 87.15% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.44% | ||
| Current month | +1.32% | ||
| 1 month | +0.66% | ||
| 3 months | -5.35% | ||
| 6 months | -7.82% | ||
| Current year | -8.00% |
1 week
4.56
4.61
1 month
4.504.72
Current year
4.495.10
1 year
4.435.76
3 years
4.438.86
5 years
4.008.86
10 years
4.0012.50
| Managers | Title | Age | Since |
|---|---|---|---|
Leslie Totté
COO | Chief Operating Officer | - | - |
Els Hubloux
CIO | Chief Investment Officer | - | - |
Ine Jordens
LAW | General Counsel | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jos B. Peeters
BRD | Director/Board Member | - | - |
Sabine Vermassen
BRD | Director/Board Member | - | - |
| Director/Board Member | - | 11-10-04 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 4.6 | +0.44% | 2,879 |
| 24-04-16 | 4.58 | -0.22% | 2,500 |
| 24-04-15 | 4.59 | +0.44% | 4,059 |
| 24-04-12 | 4.57 | -0.65% | 4,112 |
| 24-04-11 | 4.6 | 0.00% | 7,771 |
Real-time Euronext Bruxelles, April 17, 2024 at 09:34 am EDT
More quotes
Quest for Growth NV is an investment company. At the end of 2023, the portfolio, with EUR 133.1 million in market value, breaks down by type of shares as follows:
- quoted companies (63.3%);
- venture and growth funds (26.7%);
- unquoted companies (9.7%) ;
- debt securities (0.2%).
The portfolio breaks down by market between digital technologies and semiconductors (48%), cleantech (26%), pharmaceuticals and biotechnology, and medical equipment and services (24%) and other (2%).
Calendar
2024-04-25
- Q1 2024 Earnings Release
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.6
EUR
Average target price
5.9
EUR
Spread / Average Target
+28.26%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.00% | 91.19M | |
| -7.15% | 112B | |
| -1.72% | 89.73B | |
| +15.44% | 61.26B | |
| +1.07% | 58.62B | |
| +8.41% | 41.16B | |
| +4.63% | 40.38B | |
| +17.31% | 33.59B | |
| +3.44% | 25.07B | |
| -6.00% | 22.02B |
- Stock Market
- Equities
- QFG Stock
